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There are limited effective options for treatment of
triple negative breast cancer (TNBC) due to its lack of three
receptors typically used to target breast cancer- the
estrogen receptor, the progesterone receptor and the
human epidermal growth factor receptor-2. The lack of
these targets makes treatment difficult since patients with
TNBC are not candidates for hormone therapy or
trastuzumab-based regimens, which works on HER2.
Current treatments for TNBC result in poor overall survival
no matter the stage with a rapid increase in the risk of
recurrence at 1-3 years. Better treatment options are
essential to ensure better treatment and survival rates.
People of younger age, African American race, younger age
at menarche, strong family link to breast cancer, and those
with breast cancer 1 early onset (BRCA1) mutation are at
an increased risk for developing TNBC.
Photodynamic therapy (PDT) is a form of therapy
used to kill tumors. A photosensitizer (PS) is applied to the
area of treatment. Exposing the PS to light produces a
reaction with oxygen that kills both tumors and vasculature.
Foscan is a PS that has been approved for use in Europe
and is highly effective for some types of tumors. Use of this
drug necessitates that patients stay in the dark for 24 hours
after treatment because exposure to ambient light may
cause burns. One purpose of the current study is to find a
combination of porphyrin concentration and light dose that
minimizes the unwanted side effects of skin sensitivity.
One of the properties that determine how active a
PDT agent will be is how well it is taken up by cells.
Transport in the blood and uptake by cells require a balance
between the hydrophilic and hydrophobic nature of the
porphyrins. We have had difficulty measuring uptake of
some porphyrins because they stick to the plastic plates
used to grow the cells. To accurately measure uptake, it is
important to find methods to reduce background binding.
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Figure 1. Porphyrin structures.
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Results	

Uptake: For some porphyrins, binding to cells was a
modest fraction of total binding in uptake experiments. Two
methods were tried to increase the ratio of the specific
binding versus background binding of the porphyrin to the
plastic wells. Pre-treating the wells with detergents or
proteins before cells were added was not effective (data not
shown). The second method we tried was mixing
detergents or proteins with growth medium before adding
the porphyrin.
PipOH Uptake
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Table 1. Specific binding of porphyrins to MDA-MB
231 TNBC cells.

MTT assay- In the MTT assay, viable cells oxidize
the water-soluble yellow MTT to a purple insoluble
formazan. The purple precipitate is dissolved in DMSO and
quantitated by absorbance. More purple color indicates
more viable cells.
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Figure 2. Reagents to reduce background
binding. Detergents (Triton X100- 0.004%, NP-400.001%, SDS- 0.01%) and proteins (BSA- 0.01%, Gelatin0.01%) were mixed in growth medium before porphyrin
was added. Parallel plates, one with MDA-MB 231 TNBC
cells and one without cells, were treated with the porphyrin
solutions (3 wells per condition) for 24 hours and uptake
was measured. Error bars indicate standard deviations.
Results- Some reagents produced a significant
increase in binding to the cells compared to the wells. BSA
appeared to have the greatest effect. It is possible that the
reagents increase specific binding by reducing aggregation
of the hydrophobic porphyrin derivatives.

Figure 5- A 96-well plate showing variances in
purple color indicating differences in cell viability.
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Figure 6- Effects of porphyrin concentration on TNBC
cell viability in the dark and with exposure to light.
Results- Foscan shows concentration-dependent
killing of TNBC cells if they are exposed to light. In the
dark, Foscan shows little toxicity at these doses.
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Figure 3. Dependence of PipOH uptake on
concentration. 0.01% BSA was mixed into growth medium
before porphyrin was added. Medium with porphyrin was
added to parallel plates, one with MDA-MB 231 TNBC cells
and one without cells (3 wells per condition). After 24 hours
of incubation, PipOH uptake was assayed by fluorescence,
and protein assays were performed on the dissolved cells.
Standard deviations from triplicate wells are shown by error
bars.
Results- As the concentration of PipOH increases,
the amount of porphyrin taken up by the cells increases in a
linear fashion. Most of the binding is to the cells. The slope
of the regression line is a measure of the affinity of binding.
The affinity of PipOH is similar to but slightly better than that
of the previously tested porphyrins (see Table I).
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Materials and Methods	

Cell culture- MDA-MB 231 TNBC cells were grown using
published protocols. For each experiment, two sets of 96well plates were needed- one exposed to light and one kept
in the dark. Varying concentrations of porphyrins were
applied to the wells in growth medium in the dark, and the
plates were returned to the 37°C incubator. 8 wells were
used for each condition. After 24 hours, medium from both
plates was replaced with fresh culture medium. One plate
of cells was exposed to white light at (0.5 J/cm²) and both
plates were cultured in the dark for 3 days at 37°C. An MTT
assay for cell proliferation was performed on the TNBC cells
and absorbance was read on a microplate reader at a 570
nm wavelength with a 630 nm correction. Values from
replicate wells were used to calculate the average and
standard deviation. % viability was calculated by
comparison to the average of the untreated wells.
Light dose- 4 plates were grown with cells and treated
identically with different porphyrin concentrations. After 24
hours, medium with porphyrin was removed from the cells
and replaced with fresh growth medium. 3 of the plates
were exposed to varying amounts of light- 0.5, 5, or 15 J/
cm²- and returned to the 37°C incubator for 3 days in the
dark. An MTT assay was performed on the 96-well plates
to measure viability.
Uptake- Two 24-well plates were prepared, one with cells
and a parallel plate with no cells, to be treated with
porphyrins. Porphyrins were diluted into fresh growth
medium supplemented with 0.01% BSA. 0.5 ml of each
dilution was added to each of 6 wells-3 wells with and 3
wells without cells. The plates were incubated at 37°C in
the dark. After 24 hours, medium was aspirated from the
wells and the cells washed 2x with 1ml of PBS. 250 µl of
0.25% Triton X 100 in PBS was added to each well and
then incubated at 37°C in the dark. After 1 hour, the plates
were shaken for 15 minutes at room temperature. 200 µl
was removed from each well and transferred to a clean,
labeled tube. The tubes were centrifuged for 3 minutes at
16,000 x g. A fluorescence assay was performed on
aliquots of the supernatant, and the remainder of the
samples was frozen until the protein assay. A standard
curve was prepared by diluting a porphyrin standard
solution into 0.25% Triton X 100 in PBS. The fluorescence
of each dilution was measured by exciting the wells at 415
nm and reading the emission at 650 nm. The standard
curve was used to find the amount of porphyrin in each well.
Protein assays were performed on the supernatants using
the Bradford protocol.
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Figure 7. Effect of light dose on viability at varying
concentrations of Foscan (average of three experiments).
Result- At 10 nM, Foscan shows high viability up to 5
J/cm2 but significant toxicity at 15 J/cm2.
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Introduction	


Goal- To find a better treatment method for triple negative
breast cancer.
Objectives:
• Measure how well the porphyrin derivatives are taken up
by TNBC cells
• Find a combination of light dose and porphyrin
concentration that kills cells at higher doses of light but
not at moderate doses.

Light Dose- MDA-MB 231 TNBC cells were grown
on 4 96-well plates for 3 days before treating with varying
concentrations of porphyrin. After incubation for 24 hours,
the plates were exposed to varying light doses (0.5, 5, and
15 J/cm²) with 1 plate kept in the dark. After 3 more days,
wells were assayed for viability using an MTT assay.
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There are limited effective options for treatment of triple negative
breast cancer (TNBC) due to its lack of the three receptors
typically used to target breast cancer. The use of photodynamic
therapy (PDT) to kill cells that take up light-absorbing
compounds (PDT agents) may be an effective option to treat
TNBC. We tested the efficacy of modified porphyrins as PDT
agents against cells from TNBC. We compared these to Foscan,
which is similar in structure to porphyrins and has been approved
for use in Europe. Our 1st goal was to measure which porphyrins
were taken up best by TNBC cells. Measuring the uptake of
some of our compounds had been problematic due to their
hydrophobic nature. We optimized the uptake protocol and
showed that TNBC cells take up the compounds to different
extents. One of the primary side effects of PDT is skin toxicity
for up to 4-6 weeks after treatment due to exposure to sunlight.
Our 2nd goal was to compare the toxicity in the light and in the
dark of PipOH, H2TPPC, and Foscan. In previous experiments,
Foscan showed dark toxicity at low concentrations, but in these
experiments there was variability in our results with Foscan so
no clear comparison could be drawn. Our 3rd goal was to find
combinations of PDT agent and concentration that are effective
on TNBC cells at high light energy but minimize killing cells with
ambient light. We measured the effect on cell killing by varying
both the light dose and the concentration of 3 compounds to find
concentrations that are effective at high doses of light but
minimize toxicity at moderate doses. All 3 compounds show
promise, but the dose must be carefully selected.

Goals and Objectives	
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Abstract	


Porphyrins- the porphyrins used in this research were
synthesized in the lab of Joe Bradshaw. PipOH, H2TPPC,
and H2TPPSO were made by adding different side chains
with varying hydrophobic and hydrophilic properties to the R
positions of the porphyrin ring structure. Foscan has a
chlorin ring which is similar to the porphyrin ring except that
one of the C=C double bonds in one of the pyrrole rings is
reduced to a single bond.
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Figure 8. Effect of light dose on viability at varying
concentrations of PipOH and H2TPPSO (average of three
experiments).
Results- There are concentrations of both PipOH (0.3
µM) and H2TPPSO (1 µM) which show fairly high viability at
light doses up to 5 J/cm2 but increased toxicity at 15 J/cm2.
However, both show similar toxicity at 5 J/cm2 or lower
toxicity at 15 J/cm2 than does 10 nM Foscan.

Discussion 	

We were able to overcome low specific binding of
PipOH to cells by adding BSA to the growth medium prior to
adding the PipOH. This enabled us to measure affinity of
PipOH for TNBC cells. Additional experiments are
underway to measure the uptake of Foscan and H2TPPC.
We are unsure the exact extent to which Foscan is taken up
by the cells, but we do know that it is taken up much better
than any other porphyrin we have tested so far. Our results
from the light dose experiment seem promising in finding a
combination of light dose and porphyrin concentration that
minimize unwanted skin toxicity from ambient light. At 10
nM, Foscan shows high viability up to 5 J/cm2 , but
significant toxicity at 15 J/cm2. PipOH and H2TPPSO show
a similar pattern but have less separation between viability
at moderate and higher doses of light. Higher doses of light
in the clinical range of 50-200 J/cm2 need to be tested.
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